InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Earnhardt Lisa D, 首席执行官. Officer active across 2 companies, notably Abbott Laboratories. Cumulatively, 17 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €2.3m. History available since 10 June 2021. The latest transaction was disclosed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Earnhardt Lisa D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
8,577 股@ US$116.265.3% 占其流量Common shares without par valueSEC:0001530893-26-000004:0
27,056 股0Common shares without par valueSEC:0001530893-26-000002:0
91,167 股@ US$80.9842.6% 占其流量Common shares without par valueSEC:0001415889-25-007453:0
8,322 股@ US$135.876.8% 占其流量Common shares without par valueSEC:0001415889-25-006743:0
18,788 股0Common shares without par valueSEC:0001415889-25-005886:0
22,852 股@ US$106.254114.1% 占其流量Common shares without par valueSEC:0001415889-24-012624:0
7,669 股@ US$120.055.3% 占其流量Common shares without par valueSEC:0001415889-24-006405:0
17,240 股0Common shares without par valueSEC:0001415889-24-005098:0
7,631 股@ US$99.774.5% 占其流量Common shares without par valueSEC:0001415889-23-003901:0
15,855 股0Common shares without par valueSEC:0001415889-23-003050:0
19,592 股@ US$112.7112.9% 占其流量Common shares without par valueSEC:0001415889-22-006538:1
2,882 股@ US$112.710.0001% mcap22.0% 占其流量Common shares without par valueSEC:0001415889-22-006538:0
5,168 股@ US$122.413.6% 占其流量Common shares without par valueSEC:0001415889-22-002190:0
17,247 股0Common shares without par valueSEC:0001415889-22-001734:0
2,881 股@ US$109.051.6% 占其流量Common shares without par valueSEC:0001415889-21-002958:0
8,000 股Common StockSEC:0001562180-16-001352:0
12,500 股Common StockSEC:0001562180-16-001352:1
17 条申报中的 17 条
About Earnhardt Lisa D
Lisa D Earnhardt is Directeur Général, and their 17 filings relate to Abbott Laboratories and Intersect ENT, Inc. In the recent filings we hold, there were no purchases, sales total 2258612 EUR, and the period runs from 2016-01-20 to 2026-03-03. The most frequent transaction nature is Retenue fiscale.
